Limitations of the therapeutic use of superoxide dismutase Due to the instability, high immunogenicity, low cellular uptake and less in vivo circulation of the half-life of superoxide dismutase, their clinical use as therapeutic agents is very limited
In turn, ROS can damage the mitochondrial DNA or electron transport chain components, causing a further increase in ROS production or interact with mitochondrial permeability transition pore to release apoptogenic factors or with the endoplasmic reticulum (ER) to cause Ca 2+ dysregulation and ER stress (Puspita et al., 2017
Enriched with nourishing agents, it helps to hydrate and protect sensitive skin, leaving you feeling clean, fresh, and revitalized
In addition, there was a time-dependent increase of H 2 O 2 content, along with the high expression of p53 and p21 in primary hepatocytes of CCl 4 -induced rats (Supplementary Fig
doi: 10.1097/mco.0b013e328331c707